Hazard Ratios for Drug Discontinuation in Rheumatoid Arthritis Patients

5.5 KB of hazard ratios (HRs) and subdistribution hazard ratios (sHRs) for b/tsDMARD discontinuation in rheumatoid arthritis patients with or without anti-SS-A antibodies. The data was authored by Kazuma Nishisaka and last updated on March 18, 2026.

Use Cases

• Compare drug discontinuation risk based on anti-SS-A antibody status using the provided hazard ratios.
• Model competing risks in rheumatoid arthritis treatment using subdistribution hazard ratios.
• Inform clinical subgroup analysis for patients on biologic or targeted synthetic DMARDs.
• Validate findings from the referenced multicenter retrospective analysis.

Strengths

• Data is shared under a permissive CC-BY-4.0 license.
• The dataset is small (5.5 KB), facilitating quick download and inspection.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• The dataset's scope is limited to hazard ratios from a single study.

Provenance

Source

figshare

Collection Method

Likely derived from a multicenter retrospective analysis.

Freshness

Last updated 2026-03-18 17:29:37; freshness should be verified.